Anti-ceramide single-chain variable fragment mitigates radiation GI syndrome mortality independent of DNA repair

After 9/11, threat of nuclear attack on American urban centers prompted government agencies to develop medical radiation countermeasures to mitigate hematopoietic acute radiation syndrome (H-ARS) and higher-dose gastrointestinal acute radiation syndrome (GI-ARS) lethality. While repurposing leukemia...

Full description

Bibliographic Details
Main Authors: Jimmy A. Rotolo, Chii Shyang Fong, Sahra Bodo, Prashanth K.B. Nagesh, John Fuller, Thivashnee Sharma, Alessandra Piersigilli, Zhigang Zhang, Zvi Fuks, Vijay K. Singh, Richard Kolesnick
Format: Article
Language:English
Published: American Society for Clinical investigation 2021-04-01
Series:JCI Insight
Subjects:
Online Access:https://doi.org/10.1172/jci.insight.145380
_version_ 1828914284333105152
author Jimmy A. Rotolo
Chii Shyang Fong
Sahra Bodo
Prashanth K.B. Nagesh
John Fuller
Thivashnee Sharma
Alessandra Piersigilli
Zhigang Zhang
Zvi Fuks
Vijay K. Singh
Richard Kolesnick
author_facet Jimmy A. Rotolo
Chii Shyang Fong
Sahra Bodo
Prashanth K.B. Nagesh
John Fuller
Thivashnee Sharma
Alessandra Piersigilli
Zhigang Zhang
Zvi Fuks
Vijay K. Singh
Richard Kolesnick
author_sort Jimmy A. Rotolo
collection DOAJ
description After 9/11, threat of nuclear attack on American urban centers prompted government agencies to develop medical radiation countermeasures to mitigate hematopoietic acute radiation syndrome (H-ARS) and higher-dose gastrointestinal acute radiation syndrome (GI-ARS) lethality. While repurposing leukemia drugs that enhance bone marrow repopulation successfully treats H-ARS in preclinical models, no mitigator potentially deliverable under mass casualty conditions preserves GI tract. Here, we report generation of an anti-ceramide 6B5 single-chain variable fragment (scFv) and show that s.c. 6B5 scFv delivery at 24 hours after a 90% lethal GI-ARS dose of 15 Gy mitigated mouse lethality, despite administration after DNA repair was complete. We defined an alternate target to DNA repair, an evolving pattern of ceramide-mediated endothelial apoptosis after radiation, which when disrupted by 6B5 scFv, initiates a durable program of tissue repair, permitting crypt, organ, and mouse survival. We posit that successful preclinical development will render anti-ceramide 6B5 scFv a candidate for inclusion in the Strategic National Stockpile for distribution after a radiation catastrophe.
first_indexed 2024-12-13T19:51:45Z
format Article
id doaj.art-76b420606de142dd89228218364193f3
institution Directory Open Access Journal
issn 2379-3708
language English
last_indexed 2024-12-13T19:51:45Z
publishDate 2021-04-01
publisher American Society for Clinical investigation
record_format Article
series JCI Insight
spelling doaj.art-76b420606de142dd89228218364193f32022-12-21T23:33:24ZengAmerican Society for Clinical investigationJCI Insight2379-37082021-04-0168Anti-ceramide single-chain variable fragment mitigates radiation GI syndrome mortality independent of DNA repairJimmy A. RotoloChii Shyang FongSahra BodoPrashanth K.B. NageshJohn FullerThivashnee SharmaAlessandra PiersigilliZhigang ZhangZvi FuksVijay K. SinghRichard KolesnickAfter 9/11, threat of nuclear attack on American urban centers prompted government agencies to develop medical radiation countermeasures to mitigate hematopoietic acute radiation syndrome (H-ARS) and higher-dose gastrointestinal acute radiation syndrome (GI-ARS) lethality. While repurposing leukemia drugs that enhance bone marrow repopulation successfully treats H-ARS in preclinical models, no mitigator potentially deliverable under mass casualty conditions preserves GI tract. Here, we report generation of an anti-ceramide 6B5 single-chain variable fragment (scFv) and show that s.c. 6B5 scFv delivery at 24 hours after a 90% lethal GI-ARS dose of 15 Gy mitigated mouse lethality, despite administration after DNA repair was complete. We defined an alternate target to DNA repair, an evolving pattern of ceramide-mediated endothelial apoptosis after radiation, which when disrupted by 6B5 scFv, initiates a durable program of tissue repair, permitting crypt, organ, and mouse survival. We posit that successful preclinical development will render anti-ceramide 6B5 scFv a candidate for inclusion in the Strategic National Stockpile for distribution after a radiation catastrophe.https://doi.org/10.1172/jci.insight.145380Stem cellsVascular biology
spellingShingle Jimmy A. Rotolo
Chii Shyang Fong
Sahra Bodo
Prashanth K.B. Nagesh
John Fuller
Thivashnee Sharma
Alessandra Piersigilli
Zhigang Zhang
Zvi Fuks
Vijay K. Singh
Richard Kolesnick
Anti-ceramide single-chain variable fragment mitigates radiation GI syndrome mortality independent of DNA repair
JCI Insight
Stem cells
Vascular biology
title Anti-ceramide single-chain variable fragment mitigates radiation GI syndrome mortality independent of DNA repair
title_full Anti-ceramide single-chain variable fragment mitigates radiation GI syndrome mortality independent of DNA repair
title_fullStr Anti-ceramide single-chain variable fragment mitigates radiation GI syndrome mortality independent of DNA repair
title_full_unstemmed Anti-ceramide single-chain variable fragment mitigates radiation GI syndrome mortality independent of DNA repair
title_short Anti-ceramide single-chain variable fragment mitigates radiation GI syndrome mortality independent of DNA repair
title_sort anti ceramide single chain variable fragment mitigates radiation gi syndrome mortality independent of dna repair
topic Stem cells
Vascular biology
url https://doi.org/10.1172/jci.insight.145380
work_keys_str_mv AT jimmyarotolo anticeramidesinglechainvariablefragmentmitigatesradiationgisyndromemortalityindependentofdnarepair
AT chiishyangfong anticeramidesinglechainvariablefragmentmitigatesradiationgisyndromemortalityindependentofdnarepair
AT sahrabodo anticeramidesinglechainvariablefragmentmitigatesradiationgisyndromemortalityindependentofdnarepair
AT prashanthkbnagesh anticeramidesinglechainvariablefragmentmitigatesradiationgisyndromemortalityindependentofdnarepair
AT johnfuller anticeramidesinglechainvariablefragmentmitigatesradiationgisyndromemortalityindependentofdnarepair
AT thivashneesharma anticeramidesinglechainvariablefragmentmitigatesradiationgisyndromemortalityindependentofdnarepair
AT alessandrapiersigilli anticeramidesinglechainvariablefragmentmitigatesradiationgisyndromemortalityindependentofdnarepair
AT zhigangzhang anticeramidesinglechainvariablefragmentmitigatesradiationgisyndromemortalityindependentofdnarepair
AT zvifuks anticeramidesinglechainvariablefragmentmitigatesradiationgisyndromemortalityindependentofdnarepair
AT vijayksingh anticeramidesinglechainvariablefragmentmitigatesradiationgisyndromemortalityindependentofdnarepair
AT richardkolesnick anticeramidesinglechainvariablefragmentmitigatesradiationgisyndromemortalityindependentofdnarepair